SCHEMBL30452667

SCHEMBL30452667

Nc1ncc(-c2ccc3[nH]c(C(=O)NCCN4CCCC4)cc3c2)cc1OCc1c(Cl)cccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MET P08581 6/20 0.51
KDM4E B2RXH2 4/20 0.49
HSD17B10 Q99714 2/20 0.49
EGFR P00533 1/20 0.46
ERBB2 P04626 1/20 0.46
DRD2 P14416 5/20 0.46
DRD3 P35462 5/20 0.46
HTR1A P08908 1/20 0.46
HTR2C P28335 1/20 0.46
DRD4 P21917 2/20 0.44
HTR2A P28223 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
ATR Q13535 1/20 0.42
RHEB Q15382 1/20 0.41
PLD2 O14939 1/20 0.41
PLD1 Q13393 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL487484 1.00 MET (0.51) METKDM4EHSD17B10EGFRERBB2
SCHEMBL487898 0.93 MET (0.58) METKDM4EHSD17B10ERBB2DRD2
SCHEMBL30452739 0.93 MET (0.58) METKDM4EHSD17B10ERBB2DRD2
SCHEMBL487848 0.88 MET (0.49) METDRD2DRD3HTR1AHTR2C
SCHEMBL30453696 0.88 MET (0.49) METDRD2DRD3HTR1AHTR2C
SCHEMBL488203 0.82 MET (0.61) METKDM4EHSD17B10ALDH1A1
SCHEMBL30452997 0.82 MET (0.61) METKDM4EHSD17B10ALDH1A1
SCHEMBL489166 0.81 MET (0.76) METATR
SCHEMBL488405 0.81 MET (0.76) METATR
SCHEMBL30453361 0.81 MET (0.76) METATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4599890-A2 SUNITINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2025-08-13 EP disclosed
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed